, a CRO specializing in medical devices, in vitro diagnostics (IVDs), biologics, and combination products, are pleased to jointly announce that Alquest has become the first organization to join the iMedNet CRO Partner Program.  Introduced last month by MedNet Solutions, the iMedNet CRO Partner Program aims to help Clinical Research Organizations (CROs) improve research efficiency, expand their service offerings, decrease internal costs, and win more business.

"We're delighted to be the first iMedNet CRO Partner with MedNet Solutions," stated Linda Alexander, Chief Executive Officer of Alquest.  "Their new iMedNet EDC solution builds on the success of their proven ENLIGHTEN® software and brings eClinical capabilities to a whole new level.  I'm excited to show this to our clients and provide them with this state-of-the-art solution."
